title: The priming induction regimen of HAG as a low dose chemotherapy strategy in AML clonal evolution.
authors.affiliation: Key Laboratory of Genomic and Precision Medicine, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, 100101, China.
authors.forename: AiLi
authors.initials: A
authors.lastname: Chen
authors.affiliation: Key Laboratory of Genomic and Precision Medicine, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, 100101, China.
authors.forename: JingYi
authors.initials: J
authors.lastname: Yang
authors.affiliation: The Children's Hospital of Soochow University, Suzhou, 215003, China. hsy139@126.com.
authors.forename: ShaoYan
authors.initials: S
authors.lastname: Hu
authors.affiliation: Key Laboratory of Genomic and Precision Medicine, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, 100101, China. wangqf@big.ac.cn.
authors.forename: Qian-Fei
authors.initials: QF
authors.lastname: Wang
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D060965:Clonal Evolution / Q000187:drug effects* / Q000235:genetics; D003561:Cytarabine / Q000008:administration & dosage; D004305:Dose-Response Relationship, Drug; D019008:Drug Resistance, Neoplasm / Q000235:genetics; D016179:Granulocyte Colony-Stimulating Factor / Q000008:administration & dosage; D006248:Harringtonines / Q000008:administration & dosage; D000077863:Homoharringtonine; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000235:genetics; D016896:Treatment Outcome
chemical_list: D006248:Harringtonines; D003561:Cytarabine; D016179:Granulocyte Colony-Stimulating Factor; D000077863:Homoharringtonine